Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab

The Common Terminology Criteria for Adverse Events (CTCAE) were developed to document the adverse effects of chemotherapy but are now also used to document immune-related adverse events (irAE). Characterization of irAE by the CTCAE has implications for determining dose-limiting toxicity (DLT) and, c...

Full description

Bibliographic Details

Published in:	JNCI : Journal of the National Cancer Institute Vol. 109; no. 4
Main Authors:	Friedman, Claire F, Clark, Varina, Raikhel, Andrew V, Barz, Tim, Shoushtari, Alexander N, Momtaz, Parisa, Callahan, Margaret K, Wolchok, Jedd D, Chapman, Paul B, Hellmann, Matthew D, Postow, Michael A
Format:	Journal Article
Language:	English
Published:	United States 01.04.2017
Subjects:	Amylases - blood Antibodies, Monoclonal - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Female Humans Ipilimumab Lipase - blood Male Melanoma - drug therapy Pancreatitis - blood Pancreatitis - chemically induced Retrospective Studies
ISSN:	1460-2105
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!